Asthma

>

Latest News

AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Asthma Trials / image credit Alberto Papi, MD, PhD Ferarra University Italy
AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma

May 2nd 2025

The KALOS and LOGOS registration trials in patients with uncontrolled asthma compared the triple fixed dose BGF with dual combination therapy.

FDA Accepts Depemokimab BLA for Asthma and Chronic Rhinosinusitis with Nasal Polyps
FDA Accepts Depemokimab BLA for Asthma and Chronic Rhinosinusitis with Nasal Polyps

March 6th 2025

 Dupilumab, Tezepelumab Gain Ground for Severe Asthma but Overall Biologic Adherence Rates Found Low: 2 Studies from 2025 AAAAI/WAO / image credit ©molekuule.be/stock.adobe.com
Dupilumab, Tezepelumab Gain Ground for Severe Asthma but Overall Biologic Adherence Rates Found Low: 2 Studies from 2025 AAAAI/WAO

February 12th 2025

Postnatal Antibiotics for Maternal Indications May Heighten Childhood Asthma Risk / Image credit: ©DragonImages/AdobeStock
Postnatal Antibiotics for Maternal Indications May Heighten Childhood Asthma Risk

February 12th 2025

 Atopic Dermatitis First, Now Onto Asthma for Enveda's Oral Small Molecule Anti-inflammatory Candidate
Atopic Dermatitis First, Now Onto Asthma for Enveda's Oral Small Molecule Anti-inflammatory Candidate

February 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.